Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man

Hypertension

Volumn 35, Issue 4, 2000, Pages 998-1001

  Ueda, Shinichiro ^a   Masumori Maemoto, Satoko ^a   Ashino, Kazuhiro ^a   Nagahara, Toshihiro ^a   Gotoh, Eiji ^a   Umemura, Satoshi ^a   Ishii, Masao ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Angiotensin; Angiotensin II; Blood flow velocity; Noradrenaline

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN[1-7]; NORADRENALIN;

ARTICLE; BLOOD FLOW VELOCITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

EID: 0034028647     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.4.998     Document Type: Article

References (30)

1. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM. Identification of angiotensin-(1-7) in rat brain: evidence for differential processing of angiotensin peptide. J Biol Chem. 1989;264:16518-16523.
2. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Processing of angiotensin peptides by NG 108-15 neuroblastoma X glioma hybrid cell line. Peptides. 1990;11:375-380.
3. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from pocine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1994;111:652-654.
4. Trachte GJ, Meixner K, Ferrario CM, Khosla MC. Prostaglandin production in response to angiotensin-(1-7) in rabbit isolated vasa deferentia. Prostaglandins. 1990;39:385-394.
5. Jaiswal N, Tallant EA, Diz DI, Khosla MC, Ferrario CM. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension. 1991;17:1115-1120.
6. Paula RD, Lima CV, Khosla MC, Santos RAS. Angiotensin-(1-7) potentiates the hypertensive effect of bradykinin in conscious rats. Hypertension. 1995;26:1154-1159.
7. Li P, Chappell MC, Ferrario CM, Brosnihan B. Angiotensin-(1-7) augments bradykinin-induced vasodilatation by competing with ACE and releasing nitric oxide. Hypertension. 1997;29[part 2]:394-400.
8. Abbas A, Gorelik G, Carbini LA, Scicli AG. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension. 1997;30:217-221.
9. Luque M, Martin P, Martell N, Fernandez C, Brosnihan KB, Ferrario CM. Effect of captopril related to increased levels of prostacyclin and angiotensin (1-7) in essential hypertension. J Hypertens. 1996;14:799-805.
10. Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension. 1998;31:699-705.
11. Iyer SN, Ferrario CM, Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension. 1998;31(pt 2):356-361.
12. Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin (1-7). Peptides. 1993;14:679-684.
13. Mahon JM, Carr RD, Nicol AK, Henderson IW. Angiotensin (1-7) is an antagonist at the type 1 angiotensin II receptor. J Hypertens. 1994; 12: 1377-1381.
14. Kono T, Taniguchi A, Imura H, Oseko F, Khosla MC. Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man. Life Sci. 1986;38:1515-1519.
15. Deleted in proof.
16. Khosla MC, Smeby RR, Bumpus FM. Failure sequence in solid-phase peptide synthesis due to the presence of an N-alkykamino acid. J Am Chem Soc. 1972;94:4721-4724.
17. Benjamin N, Calver A, Collier J, Robinson BF, Vallance P, Webb DJ. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 1995;25:918-923.
18. Petrie JR, Ueda S, Morris AD, Elliott HL, Connell JMC. How reproducible is bilateral forearm venous occlusion plethysmography in man? Br J Clin Pharmacol. 1998;45:131-139.
19. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996;27(pt 2):523-528.
20. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol. 1995;269:H313-H319.
21. + antiporter in vascular smooth muscle cell. Hypertension. 1996;27:72-78.
22. Gruetter CA, Ryan ET, Lemke SM, Bailly DA, Fox MK, Schoepp DD. Endolhelium-dependent modulation of angiotensin II-induced contraction in blood vessels. Eur J Pharmacol. 1988;146:85-95.
23. 2 interactions in spontaneously hypertensive rats. Hypertension. 1993;22:688-698.
24. Liu SF, Crawley DE, Evans TW, Barnes P. Endogenous nitric oxide modulate adrenergic neural vasoconstriction in guinea pig pulmonary artery. Br J Pharmacol. 1991;104:565-569.
25. Urabe M, Kawasaki H, Takahashi K. Effect of endothelium-removal on the vasoconstrictor response to neuronally released 5-hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries. Br J Pharmacol. 1991;102:85-90.
26. Newby DE, Masumori S, Johnston NR, Boon NA, Webb DJ. Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man. Cardiovasc Res. 1997;36:268-275.
27. Benter IF, Diz DI, Ferrario CM. Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). Hypertension. 1995;26(pt 2):1138-1144.
28. Lawrence AC, Evin G, Kladis A, Campbell DJ. An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma. J Hypertens. 1990;8:715-722.
29. Luque M, Martin P, Nieves M, Fernandez C, Brosnihan KB, Ferrario CM. Effect of captopril related to increased levels of prostacycline and angiotensin (1-7) in essential hypertension. J Hypertens. 1996;14:799-805.
30. Juillerat L, Nussberger J, Menard J, Mooser V, Christen Y, Waeber B, Graf P, Brunnner H. Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension. 1990;16:564-572.